கருவிழி குறைந்த பிரீட்ரிச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கருவிழி குறைந்த பிரீட்ரிச். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கருவிழி குறைந்த பிரீட்ரிச் Today - Breaking & Trending Today

UCB's zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM) | Proteins and Peptides


Hits: 92
· No unexpected safety findings and no relevant safety differences between zilucoplan and placebo were identified
· Phase 3 headline results for generalized myasthenia gravis (gMG) are unchanged expected in Q4 2021
BRUSSELS, Belgium I April 22, 2021 I Based on the initial results of a Phase 2 study investigating
zilucoplan in immune-mediated necrotizing myopathy (IMNM), UCB today announced that UCB has decided to not move forward with its IMNM development program. 
The phase 2 study with
zilucoplan, a peptide inhibitor of complement component 5 (C5), in immune-mediated necrotizing myopathy (IMNM) did not show a meaningful effect of
zilucoplan for people living with IMNM. No unexpected safety findings and no relevant safety differences between ....

Bruxelles Capitale , Seanm Healey , Iris Loew Friedrich , Belgiumi April , Chief Medical Officer , Half Year Results , Generalized Myasthenia Gravis , Therapeutic Protein , Binding Proteins , ப்ரூக்ஸெல்ஸ் தலைநகரம் , கருவிழி குறைந்த பிரீட்ரிச் , தலைமை மருத்துவ அதிகாரி , பாதி ஆண்டு முடிவுகள் ,